Publisher Future Science Group has announced significant Impact Factor increases for two of its key journals - Epigenomics and Nanomedicine. The Impact Factor of Epigenomics increased 115 percent to 5.215, while Nanomedicine increased 11 percent to 5.824.
Three other titles also posted increases: Future Virology (1.0, +4%), Immunotherapy (2.44, +2%) and Future Medicinal Chemistry (4.0, +21%).
The Journal of Comparative Effectiveness Research also welcomed its first Impact Factor of 1.119. Launched in 2012, the Journal of Comparative Effectiveness Research is presently the only journal with this focus that is indexed on MEDLINE.
